Pila Pharma AB (OSTO:PILA) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 05, 2026)


OSTO:PILA Pila Pharma AB OSTO:PILA
49 GF Score
Price kr1.24
GF Value kr1.83
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Pila Pharma AB Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Pila Pharma AB's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

OSTO:PILA vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Pila Pharma AB's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pila Pharma AB Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pila Pharma AB's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Pila Pharma AB's Margin of Safety % (DCF FCF Based) falls into.


OSTO:PILA
49GF Score
Pila Pharma AB OSTO:PILA
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pila Pharma AB (OSTO:PILA) Overvalued in 2026?

Based on GuruFocus' analysis, Pila Pharma AB stock appears to be undervalued. The current stock price of kr1.24 is trading 32.5% below its estimated GF Value™ of kr1.83. GuruFocus considers Pila Pharma AB to be Significantly Undervalued.

Key valuation signals for OSTO:PILA:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: kr1.83 vs. price of kr1.24 (32.5% below fair value)
  • GF Score™: 49/100 with 3 warning signs

No single metric tells the full story. See the OSTO:PILA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pila Pharma AB Business Description

Address Norra Vallgatan 72, Malmo, SWE, 211 21
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.
49GF Score

Get the complete analysis for OSTO:PILA

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.24
Price
kr1.83
GF Value